Pit Ullmann
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer Cells and Metastasis
Papers in
-
- Cancer, Hypoxia, and Metabolism 3
- MicroRNA in disease regulation 3
- Cancer Genomics and Diagnostics 1
- Oncology 8
- Cancer Cells and Metastasis 8
- Co-authors
- Elisabeth Letellier (10 shared papers)Serge Haan (10 shared papers)Fabien Rodriguez (7 shared papers)Martin Nurmik (4 shared papers)Komal Qureshi-Baig (7 shared papers)Sónia Frasquilho (4 shared papers)Martine Schmitz (4 shared papers)Petr V. Nazarov (3 shared papers)
- Journals
- Nature Communications (1 paper)Oncotarget (1 paper)Autophagy (1 paper)Cells (1 paper)Molecular Cancer (1 paper)
- Partner nations
- LuxembourgGermanyAustria
In The Last Decade
Pit Ullmann
11 papers receiving 1.2k citations
Pit Ullmann's Hit Papers
Peers
Comparison fields: 5 of 84
- Cancer Research 423
- Oncology 513
- Molecular Biology 571
- Immunology 163
- Biotechnology 43
Countries citing papers authored by Pit Ullmann
This map shows the geographic impact of Pit Ullmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pit Ullmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pit Ullmann more than expected).
Fields of papers citing papers by Pit Ullmann
This network shows the impact of papers produced by Pit Ullmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pit Ullmann. The network helps show where Pit Ullmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Pit Ullmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | In search of definitions: Cancer‐associated fibroblasts and their markers Hit paper breakdown → | 2019 | 553 |
| 2 | 2019 | 153 | |
| 3 | 2023 | 87 | |
| 4 | 2017 | 81 | |
| 5 | 2019 | 78 | |
| 6 | 2019 | 70 | |
| 7 | 2016 | 51 | |
| 8 | 2016 | 50 | |
| 9 | 2019 | 50 | |
| 10 | 2018 | 39 | |
| 11 | 2017 | 35 |
About Pit Ullmann
Pit Ullmann is a scholar working on Cancer Research, Oncology, Molecular Biology, Pharmacology and Biotechnology, having authored 11 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (8 papers), Cancer, Hypoxia, and Metabolism (3 papers), Epigenetics and DNA Methylation (3 papers), MicroRNA in disease regulation (3 papers), Cancer Genomics and Diagnostics (1 paper), Cancer Research and Treatments (1 paper), RNA modifications and cancer (1 paper) and FOXO transcription factor regulation (1 paper). The work is most often cited by research in Cancer Research (423 citations), Oncology (513 citations), Molecular Biology (571 citations), Immunology (163 citations) and Biotechnology (43 citations). Pit Ullmann has collaborated with scholars based in Luxembourg, Germany and Austria. Frequent co-authors include Elisabeth Letellier, Serge Haan, Fabien Rodriguez, Martin Nurmik, Komal Qureshi-Baig, Sónia Frasquilho, Martine Schmitz, Petr V. Nazarov, Laurent Antunes and Nikolaus Zuegel. Their work appears in journals such as Nature Communications, Oncotarget, Autophagy, Cells and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.